Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) Invested Capital (2023 - 2025)

Metagenomi (MGX) has disclosed Invested Capital for 3 consecutive years, with $158.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital fell 32.47% to $158.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $158.6 million, a 32.47% decrease, with the full-year FY2025 number at $158.6 million, down 32.47% from a year prior.
  • Invested Capital was $158.6 million for Q4 2025 at Metagenomi, down from $178.4 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $275.6 million in Q1 2024 to a low of -$135.6 million in Q4 2023.
  • A 3-year average of $121.1 million and a median of $187.1 million in 2025 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: surged 214997.37% in 2024, then tumbled 32.47% in 2025.
  • Metagenomi's Invested Capital stood at -$135.6 million in 2023, then surged by 273.22% to $234.9 million in 2024, then crashed by 32.47% to $158.6 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Invested Capital are $158.6 million (Q4 2025), $178.4 million (Q3 2025), and $195.8 million (Q2 2025).